Compare SVRA & DCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVRA | DCH |
|---|---|---|
| Founded | 2007 | 1994 |
| Country | United States | United States |
| Employees | N/A | 18000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2009 | N/A |
| Metric | SVRA | DCH |
|---|---|---|
| Price | $6.22 | $5.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $7.33 | ★ $10.50 |
| AVG Volume (30 Days) | 2.0M | ★ 4.1M |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $82.65 |
| Revenue Next Year | $430.87 | $4.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.14 | $4.92 |
| 52 Week High | $7.01 | $8.75 |
| Indicator | SVRA | DCH |
|---|---|---|
| Relative Strength Index (RSI) | 70.02 | 35.45 |
| Support Level | $5.86 | N/A |
| Resistance Level | $6.49 | $6.93 |
| Average True Range (ATR) | 0.25 | 0.32 |
| MACD | 0.07 | -0.12 |
| Stochastic Oscillator | 90.83 | 8.00 |
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Dauch Corp is a world-wide Tier 1 Automotive Supplier, Dauch designs, engineers and manufactures Driveline and Metal Forming technologies to support electric, hybrid and internal combustion vehicles.